28/Apr/2025
Quality assessment of clinical practice in neuro-oncology
DOI: 10.31744/einstein_journal/2025AO1343
Highlights ■ The molecular test according to the WHO classification of CNS tumors (gliomas) was performed in 100% (172) of patients. ■ Education on chemotherapy and informed consent for patients with brain tumors was carried out for 100% (130) of the patients who had an indication for chemotherapy treatment. ■ Approximately 87% of the patients with gliomas underwent postoperative cranial MRI. ■ A multidisciplinary approach, including molecular testing, was used for 35% of patients with glioma. ■ Thromboembolic events after […]
Keywords: Brain neoplasms; Central nervous system neoplasms; Glioma; Length of stay; Magnetic resonance imaging; Meningioma; Patient outcome assessment; Postoperative complications; Quality improvement; Quality Indicators, Health Care
01/Jul/2010
Magnetohyperthermia for treatment of gliomas: experimental and clinical studies
DOI: 10.1590/S1679-45082010RW1757
ABSTRACT Gliomas comprise a group of heterogeneous primary tumors of the central nervous system that originate from glial cells. Malignant gliomas account for the majority of primary malignant CNS tumors and are associated with high morbidity and mortality. Glioblastoma is the most frequent malignant glioma, and despite recent advances in diagnosis and new treatment options, its prognosis remains dismal. New opportunities for the development of effective therapies for malignant gliomas are urgently needed. Magnetohyperthermia consists of heat generation in the […]
Keywords: Central nervous system neoplasms; Glioma; Hyperthermia, induced; Magnetics; Models, animal; Nanoparticles